Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
Cardiol Rev
; 28(6): 303-307, 2020.
Article
in English
| MEDLINE | ID: covidwho-970240
ABSTRACT
Severe acute respiratory distress syndrome coronavirus 2 (COVID-19) is the cause of the current pandemic, which remains a tremendous cause of morbidity and mortality worldwide. Although there are numerous trials underway, there is currently no medication known to cure the infection. Nonsteroidal anti-inflammatory drugs (NSAIDs) are inexpensive, widely available medications with antiviral and anti-inflammatory properties and may have utility as an adjunct therapy to improve outcomes in patients with severe COVID-19 infection. A thorough PubMed literature review on the therapeutic use of NSAID was conducted to provide a comprehensive perspective of the role of NSAIDs in treating COVID-19. NSAIDs may be a useful adjunct therapy for patients with severe COVID-19 infection, but further investigation and clinical trials are necessary to ensure their safety and efficacy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Anti-Inflammatory Agents, Non-Steroidal
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Prognostic study
/
Reviews
Limits:
Humans
Language:
English
Journal:
Cardiol Rev
Journal subject:
Vascular Diseases
/
Cardiology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS